Oversight of fast-track drug approval by FDA stuck in low gear, critics say

JAMA. 2010 Oct 27;304(16):1773-5. doi: 10.1001/jama.2010.1486.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval*
  • Hypotension, Orthostatic / drug therapy
  • Midodrine / therapeutic use
  • Product Surveillance, Postmarketing*
  • Time Factors
  • United States
  • United States Food and Drug Administration*
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents
  • Midodrine